Female astronauts can be affected with the risk of blood clots associated with spaceflight.
Geriatric Pregnancy or Pregnancy in Women of Advanced Maternal Age
Pregnancy in advanced maternal age refers to women who conceive after 35 years. Maintaining a healthy lifestyle and taking certain precautions maximizes the possibility of a healthy pregnancy.
Pregnancy in advanced maternal age refers to women who conceive after 35 years. Maintaining a healthy lifestyle and taking certain precautions maximizes the possibility of a healthy pregnancy.
‘The study, published in Aerospace Medicine and Human Performance, in collaboration with King's College London, the Centre for Space Medicine Baylor College of Medicine, NASA Johnson Space Centre and the International Space University, examines the potential risk factors for developing a blood clot (venous thromboembolism) in space.
The findings, which looked at 38 female astronaut flights between 2000 and 2014, found spaceflight and combined oral contraceptive pill (COCP) use does not appear to increase the risk of venous thromboemoblism (VTE).
Dr Varsha Jain, lead author of the study from King's College London and a Wellbeing of Women Clinical Research Fellow at the Medical Research Council Centre for Reproductive Health at the University of Edinburgh, said: "The first episode of an astronaut developing a blood clot in space was reported earlier this year.
![Iron Supplements for Women - Benefits, Side-effects]( "Iron Supplements for Women - Benefits, Side-effects")
It is unknown how spaceflight impacts the risk of an astronaut developing a blood clot. This study aimed to look specifically at the potential blood clot developing risks for female astronauts during spaceflight. We wanted to understand if their use of the hormonal contraceptive pill for menstrual cycle control, increased that risk."
Developing a VTE in space is life threatening and potentially a mission critical risk.
![About Cancer in Women]( "About Cancer in Women")
The risk may have been further increased by COCP use, however as female astronauts are more fit and healthy than general population, their risk remains low.
The study, which is the first of its kind, proposes more blood tests be carried out during astronaut selection and during medical reviews. There are points during pre-mission training and during spaceflight, such as particular training activities, which may briefly increase the risk of developing a blood clot, and the authors recommend a review of these.
![Best Workout Routines for Women]( "Best Workout Routines for Women")
Finally, the study advises a more holistic approach to be taken for contraceptive agent prescribing as women from all professions, including astronauts, may wish to control their menstrual cycles and occupation related risks should be considered during a risk review.
Dr Jain said: "There may be possible time points in an astronaut's pre-mission training or during the space mission itself where blood clot risk may potentially be transiently increased.
Due to the potentially life-threatening nature of blood clots, we would advise further targeted research in this area to further understand how an astronaut's risk of developing a blood clot is altered by spaceflight."
Dr Virginia Wotring, associate Professor at the International Space University and senior author of the study, said: "We see a need for continuing studies with female astronauts. Much of the previous biomedical research in space was conducted on mostly male astronauts, because most of the astronauts were male.
That has changed, and now we need to understand how the spaceflight environment impacts female physiology."’
The findings, which looked at 38 female astronaut flights between 2000 and 2014, found spaceflight and combined oral contraceptive pill (COCP) use does not appear to increase the risk of venous thromboemoblism (VTE).
The findings, which looked at 38 female astronaut flights between 2000 and 2014, found spaceflight and combined oral contraceptive pill (COCP) use does not appear to increase the risk of venous thromboemoblism (VTE).
Dr Varsha Jain, lead author of the study from King's College London and a Wellbeing of Women Clinical Research Fellow at the Medical Research Council Centre for Reproductive Health at the University of Edinburgh, said: "The first episode of an astronaut developing a blood clot in space was reported earlier this year.
Iron Supplements for Women - Benefits, Side-effects
Iron supplements are used to treat anemia and iron deficiency in women. Iron an essential mineral plays key role in making of red blood cells, which carry oxygen.
Iron supplements are used to treat anemia and iron deficiency in women. Iron an essential mineral plays key role in making of red blood cells, which carry oxygen.
Developing a VTE in space is life threatening and potentially a mission critical risk.
Advertisement
About Cancer in Women
Cancer is one of the frequently talked about and most feared disease that falls under the genre of lifestyle diseases that have evolved, rather rapidly, in the past two decades.
Cancer is one of the frequently talked about and most feared disease that falls under the genre of lifestyle diseases that have evolved, rather rapidly, in the past two decades.
The study, which is the first of its kind, proposes more blood tests be carried out during astronaut selection and during medical reviews. There are points during pre-mission training and during spaceflight, such as particular training activities, which may briefly increase the risk of developing a blood clot, and the authors recommend a review of these.
Advertisement
Best Workout Routines for Women
The myriad of exercises available for women today to achieve the perfect body can leave them confused.
The myriad of exercises available for women today to achieve the perfect body can leave them confused.
Dr Jain said: "There may be possible time points in an astronaut's pre-mission training or during the space mission itself where blood clot risk may potentially be transiently increased.
Due to the potentially life-threatening nature of blood clots, we would advise further targeted research in this area to further understand how an astronaut's risk of developing a blood clot is altered by spaceflight."
Dr Virginia Wotring, associate Professor at the International Space University and senior author of the study, said: "We see a need for continuing studies with female astronauts. Much of the previous biomedical research in space was conducted on mostly male astronauts, because most of the astronauts were male.
That has changed, and now we need to understand how the spaceflight environment impacts female physiology."’
Dr Varsha Jain, lead author of the study from King’s College London and a Wellbeing of Women Clinical Research Fellow at the Medical Research Council Centre for Reproductive Health at the University of Edinburgh, said: "The first episode of an astronaut developing a blood clot in space was reported earlier this year.
It is unknown how spaceflight impacts the risk of an astronaut developing a blood clot. This study aimed to look specifically at the potential blood clot developing risks for female astronauts during spaceflight. We wanted to understand if their use of the hormonal contraceptive pill for menstrual cycle control, increased that risk."
Developing a VTE in space is life threatening and potentially a mission critical risk.
The risk may have been further increased by COCP use, however as female astronauts are more fit and healthy than general population, their risk remains low.
The study, which is the first of its kind, proposes more blood tests be carried out during astronaut selection and during medical reviews. There are points during pre-mission training and during spaceflight, such as particular training activities, which may briefly increase the risk of developing a blood clot, and the authors recommend a review of these.
Finally, the study advises a more holistic approach to be taken for contraceptive agent prescribing as women from all professions, including astronauts, may wish to control their menstrual cycles and occupation related risks should be considered during a risk review.
Dr Jain said: "There may be possible time points in an astronaut’s pre-mission training or during the space mission itself where blood clot risk may potentially be transiently increased.
Due to the potentially life-threatening nature of blood clots, we would advise further targeted research in this area to further understand how an astronaut’s risk of developing a blood clot is altered by spaceflight."
Dr Virginia Wotring, associate Professor at the International Space University and senior author of the study, said: "We see a need for continuing studies with female astronauts. The study, published in Aerospace Medicine and Human Performance, in collaboration with King’s College London, the Centre for Space Medicine Baylor College of Medicine, NASA Johnson Space Centre and the International Space University, examines the potential risk factors for developing a blood clot (venous thromboembolism) in space.
The findings, which looked at 38 female astronaut flights between 2000 and 2014, found spaceflight and combined oral contraceptive pill (COCP) use does not appear to increase the risk of venous thromboemoblism (VTE).
Dr Varsha Jain, lead author of the study from King’s College London and a Wellbeing of Women Clinical Research Fellow at the Medical Research Council Centre for Reproductive Health at the University of Edinburgh, said: "The first episode of an astronaut developing a blood clot in space was reported earlier this year.
It is unknown how spaceflight impacts the risk of an astronaut developing a blood clot. This study aimed to look specifically at the potential blood clot developing risks for female astronauts during spaceflight. We wanted to understand if their use of the hormonal contraceptive pill for menstrual cycle control, increased that risk."
Developing a VTE in space is life threatening and potentially a mission critical risk.
The risk may have been further increased by COCP use, however as female astronauts are more fit and healthy than general population, their risk remains low.
The study, which is the first of its kind, proposes more blood tests be carried out during astronaut selection and during medical reviews. There are points during pre-mission training and during spaceflight, such as particular training activities, which may briefly increase the risk of developing a blood clot, and the authors recommend a review of these.
Finally, the study advises a more holistic approach to be taken for contraceptive agent prescribing as women from all professions, including astronauts, may wish to control their menstrual cycles and occupation related risks should be considered during a risk review.
Dr Jain said: "There may be possible time points in an astronaut’s pre-mission training or during the space mission itself where blood clot risk may potentially be transiently increased.
Due to the potentially life-threatening nature of blood clots, we would advise further targeted research in this area to further understand how an astronaut’s risk of developing a blood clot is altered by spaceflight."
Dr Virginia Wotring, associate Professor at the International Space University and senior author of the study, said: "We see a need for continuing studies with female astronauts. Much of the previous biomedical research in space was conducted on mostly male astronauts, because most of the astronauts were male.
That has changed, and now we need to understand how the spaceflight environment impacts female physiology."
That has changed, and now we need to understand how the spaceflight environment impacts female physiology."
Source-Eurekalert
